MEKanistic Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- MEKanistic Therapeutics's estimated annual revenue is currently $852.5k per year.
- MEKanistic Therapeutics's estimated revenue per employee is $77,500
Employee Data
- MEKanistic Therapeutics has 11 Employees.
- MEKanistic Therapeutics grew their employee count by 0% last year.
MEKanistic Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | COO | Reveal Email/Phone |
MEKanistic Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.3M | 60 | 20% | N/A | N/A |
#2 | $9.1M | 59 | -34% | N/A | N/A |
#3 | $1.1M | 7 | 17% | N/A | N/A |
#4 | $0.3M | 2 | -93% | N/A | N/A |
#5 | $4.3M | 28 | 4% | N/A | N/A |
#6 | $1.4M | 9 | 50% | N/A | N/A |
#7 | $6M | 39 | 3% | N/A | N/A |
#8 | $15.8M | 102 | 7% | N/A | N/A |
#9 | $18M | 116 | 0% | $20.5M | N/A |
#10 | $34.1M | 176 | 13% | $39.1M | N/A |
What Is MEKanistic Therapeutics?
Led by cancer research pioneers, MEKanistic is advancing a novel class of selective kinase inhibitors rationally designed to target both EGFR and PI3K with a single molecule. This breakthrough design expands the therapeutic window by inhibiting compensatory resistance pathways at the same time, avoiding inherent toxicity challenges of multi-compound treatments.
keywords:N/A
N/A
Total Funding
11
Number of Employees
$852.5k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Minneapolis
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 11 | N/A | N/A |
#2 | $1M | 11 | N/A | N/A |
#3 | $1.4M | 11 | 0% | N/A |
#4 | $1.6M | 11 | 0% | N/A |
#5 | $1M | 11 | -21% | N/A |